Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley
| Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2020 |
| Descrizione fisica | 1 online resource (26 pages) : color illustrations, color maps |
| Collana | Testimony |
| Soggetto topico |
COVID-19 (Disease) - Treatment - United States
Drugs - Inspection - United States Drugs - United States - Safety measures - Evaluation Pharmaceutical industry - Quality control - Evaluation Drugs - Safety regulations - United States - Evaluation Drug reimportation - United States - Evaluation Imports - United States - Safety measures - Evaluation |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910713508703321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety
| FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2013 |
| Descrizione fisica | 1 online resource (34 pages) : illustrations |
| Soggetto topico |
Medicare
Drugs - Risk assessment - United States - Evaluation Drugs - United States - Safety measures - Evaluation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Food and Drug Administration lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety
FDA lacks comprehensive data to determine whether REMS improve drug safety |
| Record Nr. | UNINA-9910707255503321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
